• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/28/25 4:15:30 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials
    Get the next $TMO alert in real time by email
    tmo-20250521
    0000097745FALSE00000977452025-05-212025-05-210000097745us-gaap:CommonStockMember2025-05-212025-05-210000097745tmo:SeniorNotes3200Due2026Member2025-05-212025-05-210000097745tmo:SeniorNotes1.40Due2026Member2025-05-212025-05-210000097745tmo:A1.45SeniorNotesDue2027Member2025-05-212025-05-210000097745tmo:SeniorNotes175Due2027Member2025-05-212025-05-210000097745tmo:SeniorNotes0.500Due2028Member2025-05-212025-05-210000097745tmo:SeniorNotes1.375Due2028Member2025-05-212025-05-210000097745tmo:SeniorNotes1.95Due2029Member2025-05-212025-05-210000097745tmo:SeniorNotes0.875Due2031Member2025-05-212025-05-210000097745tmo:SeniorNotes2375Due2032Member2025-05-212025-05-210000097745tmo:SeniorNotes3650Due2034Member2025-05-212025-05-210000097745tmo:SeniorNotes2.875Due2037Member2025-05-212025-05-210000097745tmo:SeniorNotes1.500Due2039Member2025-05-212025-05-210000097745tmo:SeniorNotes1.875Due2049Member2025-05-212025-05-21

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 21, 2025

    THERMO FISHER SCIENTIFIC INC.
    (Exact name of Registrant as specified in its Charter)
    Delaware1-800204-2209186
    (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

    168 Third Avenue
    Waltham, Massachusetts 02451
    (Address of principal executive offices) (Zip Code)

    Registrant’s telephone number, including area code: (781) 622-1000
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, $1.00 par valueTMONew York Stock Exchange
    3.200% Notes due 2026TMO 26BNew York Stock Exchange
    1.400% Notes due 2026TMO 26ANew York Stock Exchange
    1.450% Notes due 2027TMO 27New York Stock Exchange
    1.750% Notes due 2027TMO 27BNew York Stock Exchange
    0.500% Notes due 2028TMO 28ANew York Stock Exchange
    1.375% Notes due 2028TMO 28New York Stock Exchange
    1.950% Notes due 2029TMO 29New York Stock Exchange
    0.875% Notes due 2031TMO 31New York Stock Exchange
    2.375% Notes due 2032TMO 32New York Stock Exchange
    3.650% Notes due 2034TMO 34New York Stock Exchange
    2.875% Notes due 2037TMO 37New York Stock Exchange
    1.500% Notes due 2039TMO 39New York Stock Exchange
    1.875% Notes due 2049TMO 49New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐  

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



    Item 5.07    Submission of Matters to a Vote of Security Holders
    At the Annual Meeting held on May 21, 2025, the shareholders of the Company voted on the following proposals:
    1.    The following nominees were elected to the Company’s Board of Directors for a one-year term expiring at the 2026 annual meeting of shareholders.
    ForAgainstAbstainBroker Non-Votes
    Marc N. Casper288,144,302 25,678,666 2,486,405 18,072,525 
    Nelson J. Chai296,784,356 18,421,795 1,103,222 18,072,525 
    Ruby R. Chandy
    313,439,920 2,495,128 374,325 18,072,525 
    C. Martin Harris297,504,154 18,426,884 378,335 18,072,525 
    Tyler Jacks309,910,625 6,020,753 377,995 18,072,525 
    Jennifer M. Johnson
    309,171,010 6,591,555 546,808 18,072,525 
    R. Alexandra Keith309,795,805 5,979,780 533,788 18,072,525 
    Karen S. Lynch315,639,296 295,640 374,437 18,072,525 
    James C. Mullen309,634,753 6,294,017 380,603 18,072,525 
    Debora L. Spar315,509,501 426,032 373,840 18,072,525 
    Scott M. Sperling297,998,762 17,930,767 379,844 18,072,525 
    Dion J. Weisler274,603,443 41,325,407 380,523 18,072,525 

    2.    A non-binding, advisory proposal on the compensation of the Company’s named executive officers was not approved.
    ForAgainstAbstainBroker Non-Votes
    111,099,532 201,378,177 3,831,664 18,072,525 

    3.    The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025 was ratified.
    ForAgainstAbstain
    295,910,313 38,096,113 375,472 

    4.    The shareholder proposal to remove the one year holding period requirement to call a special meeting was not approved.
    ForAgainstAbstainBroker Non-Votes
    25,723,747 289,719,925 865,701 18,072,525 




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    THERMO FISHER SCIENTIFIC INC.
    Date:May 28, 2025By:/s/ Michael A. Boxer
    Michael A. Boxer
    Senior Vice President and General Counsel


    Get the next $TMO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TMO

    DatePrice TargetRatingAnalyst
    1/10/2025$630.00Mkt Perform → Outperform
    Bernstein
    12/23/2024Sector Perform
    Scotiabank
    10/14/2024Buy
    Redburn Atlantic
    10/1/2024$680.00Overweight
    Stephens
    8/28/2024$670.00Overweight
    Wells Fargo
    6/3/2024$650.00Buy
    Jefferies
    3/18/2024$620.00Neutral
    Citigroup
    1/24/2024$475.00 → $555.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $TMO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • 908 Devices Appoints Christopher D. Brown to its Board of Directors

      908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead

      6/16/25 8:00:00 AM ET
      $AAPL
      $MASS
      $RGEN
      $TMO
      Computer Manufacturing
      Technology
      Industrial Machinery/Components
      Industrials
    • Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research

      Orbitrap Astral Zoom and Orbitrap Excedion Pro deliver increased speed and sensitivity to set a new performance benchmark for high-resolution, accurate mass spectrometry Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectrometer (MS) and the Thermo Scientific™ Orbitrap™ Excedion™ Pro mass spectrometer (MS) to help push the boundaries of scientific discovery. Delivering unrivaled analytical performance and speed, the instruments are designed to uncover complex biological processes that could lead to advancements in precision medicine and significant insights for complex disease

      6/2/25 8:00:00 AM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • Thermo Fisher Scientific Declares Quarterly Dividend

      Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on July 15, 2025, to shareholders of record as of June 13, 2025. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the developmen

      5/21/25 4:15:00 PM ET
      $TMO
      Industrial Machinery/Components
      Industrials

    $TMO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Thermo Fisher upgraded by Bernstein with a new price target

      Bernstein upgraded Thermo Fisher from Mkt Perform to Outperform and set a new price target of $630.00

      1/10/25 8:42:46 AM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • Scotiabank initiated coverage on Thermo Fisher

      Scotiabank initiated coverage of Thermo Fisher with a rating of Sector Perform

      12/23/24 8:24:48 AM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • Redburn Atlantic initiated coverage on Thermo Fisher

      Redburn Atlantic initiated coverage of Thermo Fisher with a rating of Buy

      10/14/24 9:24:58 AM ET
      $TMO
      Industrial Machinery/Components
      Industrials

    $TMO
    SEC Filings

    See more
    • SEC Form 11-K filed by Thermo Fisher Scientific Inc

      11-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)

      6/17/25 2:30:55 PM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • SEC Form SD filed by Thermo Fisher Scientific Inc

      SD - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)

      5/30/25 7:32:53 AM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)

      5/28/25 4:15:30 PM ET
      $TMO
      Industrial Machinery/Components
      Industrials

    $TMO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Chai Nelson sold $8,449 worth of shares (16 units at $528.09) and bought $11,038 worth of shares (20 units at $551.90), increasing direct ownership by 0.03% to 14,252 units (SEC Form 4)

      4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

      2/21/25 4:19:32 PM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • Boxer Michael A bought $2,105 worth of shares (4 units at $526.15), increasing direct ownership by 0.03% to 13,101 units (SEC Form 4)

      4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

      10/6/23 4:23:51 PM ET
      $TMO
      Industrial Machinery/Components
      Industrials

    $TMO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP and General Counsel Shropshire Thomas B Jr. was granted 5,417 shares (SEC Form 4)

      4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

      6/3/25 4:38:07 PM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • SEC Form 3 filed by new insider Shropshire Thomas B Jr.

      3 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

      6/3/25 4:35:51 PM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • SEC Form 4 filed by Chairman & CEO Casper Marc N

      4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

      5/22/25 4:53:02 PM ET
      $TMO
      Industrial Machinery/Components
      Industrials

    $TMO
    Financials

    Live finance-specific insights

    See more
    • Thermo Fisher Scientific Declares Quarterly Dividend

      Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on July 15, 2025, to shareholders of record as of June 13, 2025. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the developmen

      5/21/25 4:15:00 PM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • Thermo Fisher Scientific Reports First Quarter 2025 Results

      Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 29, 2025. First Quarter Highlights First quarter revenue was $10.36 billion. First quarter GAAP diluted earnings per share (EPS) grew 15% to $3.98. First quarter adjusted EPS grew 1% to $5.15. Delivered very strong financial performance in the quarter, demonstrating the strength of our trusted partner status and the power of our PPI Business System in a more uncertain macroeconomic environment. Advanced our proven growth strategy, launching a range of high-impact, innovative new products during the quarter. To transform semiconduc

      4/23/25 6:00:00 AM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 23, 2025

      Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2025 before the market opens on Wednesday, April 23, 2025, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. The access code is 074131. You may also listen to the call live on the "Investors" section of our website, www.thermofisher.com. The earnings press release and related information can also be found in that section of our website under th

      4/1/25 8:00:00 AM ET
      $TMO
      Industrial Machinery/Components
      Industrials

    $TMO
    Leadership Updates

    Live Leadership Updates

    See more
    • 908 Devices Appoints Christopher D. Brown to its Board of Directors

      908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead

      6/16/25 8:00:00 AM ET
      $AAPL
      $MASS
      $RGEN
      $TMO
      Computer Manufacturing
      Technology
      Industrial Machinery/Components
      Industrials
    • GeminiBio Appoints Mike Stella to Board

      Strengthening Board with Industry Veterans Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based healthcare private equity firm, announced today the appointment of Michael Stella to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218608576/en/Mike Stella, CEO of Ascend Advanced Therapies, joins the Board at GeminiBio to provide strategic leadership in the fields of cell and gene therapy contract development and manufacturing. (Photo: Business Wire) GeminiBio prov

      2/18/25 9:00:00 AM ET
      $AMGN
      $GSK
      $JNJ
      $MRK
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Industrial Machinery/Components
    • Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company's Proposed Merger with Standard BioTools

      Files Preliminary Proxy Statement to Solicit Shareholders to Oppose the Merger Intends to Vote AGAINST the Conflict-Plagued and Excessively Dilutive Transaction, Which Stands to Unduly Benefit Certain Investors and Standard BioTools at the Expense of SomaLogic's Shareholders Notes the Current Premium for SomaLogic Shareholders, Based on the Deal's Exchange Ratio and Standard BioTools' Trading Price, is Only ~4.3% Underscores That SomaLogic Has Superior Alternatives to a Flawed Combination, Including a Standalone Path Leveraging its Considerable Cash Position and Strong Balance Sheet Madryn Asset Management, LP (collectively with its affiliates, "Madryn"), a holder of approximately 4

      12/12/23 5:31:00 PM ET
      $EXAS
      $ILMN
      $LAB
      $ME
      Medical Specialities
      Health Care
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $TMO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Thermo Fisher Scientific Inc (Amendment)

      SC 13G/A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)

      2/9/23 11:35:13 AM ET
      $TMO
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed

      SC 13G/A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)

      2/10/21 11:57:23 AM ET
      $TMO
      Industrial Machinery/Components
      Industrials